Meds in Motion Frequently Asked Questions (FAQ)
When was Meds in Motion founded?
Meds in Motion was founded in 2018.
Where is Meds in Motion's headquarters?
Meds in Motion's headquarters is located at 12101 S. State Street, Draper.
What is Meds in Motion's latest funding round?
Meds in Motion's latest funding round is Loan.
How much did Meds in Motion raise?
Meds in Motion raised a total of $680K.
Who are the investors of Meds in Motion?
Investors of Meds in Motion include Paycheck Protection Program.
Who are Meds in Motion's competitors?
Competitors of Meds in Motion include divvyDOSE and 4 more.
Compare Meds in Motion to Competitors
Nimble operates as a digital health company. It provides prescription delivery services. It works with pharmacies and insurance companies to deliver prescriptions directly to patients. It was formerly known as Nimble Pharmacy. The company was founded in 2015 and is based in Redwood City, California.
Truepill provides an online pharmacy platform. The company offers telehealth and diagnostics services delivering its patients through its application programming interface (API) driven healthcare infrastructure. Truepill was formerly known as PostMeds. The company was founded in 2016 and is based in Hayward, California.
Alto Pharmacy operates as a digital pharmacy. It delivers prescriptions, offers personalized in-application and phone support, and coordination with doctors and insurance companies. It was formerly known as ScriptDash. It was founded in 2015 and is based in San Francisco, California.
ExactCare is a full-service pharmacy that specializes in medication management for patients with multiple disease states, on multiple medications. The company's pharmacy solution includes an in-home patient assessment; medication reconciliation and medication therapy management performed by clinical pharmacists; monthly refill management; customized adherence packaging; and home delivery. ExactCare's approach to pharmacy helps patients overcome the challenges of polypharmacy and health care providers and payers achieve better clinical and economic outcomes.
Biophan is dedicated to providing technologies that offer innovative andcompetitive advantages to the medical device industry. The Company ishelping to commercialize the Myotech Circulatory Support System, which has potential to improve the treatment of acute heart failure.Biophan Technologies, Inc. holds a 68% interest in Myotech. Biophan istraded on the OTC market under the symbol BIPH, and is also listed on theFrankfurt Stock Exchange under the symbol BTN.
findtheDOT designs and develops technology to match medications to patients and physician orders. The Company's printed code mark and portable, wireless code reader provide a practical means of validating medications at the patient bedside.